• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

Brief cognitive screening tool in development

October 5, 2013  

HSCT in aggressive MS: Canadian MS/BMT Study Group results

October 5, 2013  

Lateral switch vs. escalation: 2 reports

October 5, 2013  

Identifying SPMS in practice

October 4, 2013  

MS therapies: analyses and re-analyses of phase III studies

October 4, 2013  

Dietary sodium linked to increased disease activity in MS

October 4, 2013  

MRI measures provide reliable indication of treatment response

October 3, 2013  

Better prognosis for OCB-negative patients

October 3, 2013  

Vitamin D a useful add-on treatment in MS

October 3, 2013  

Optimizing treatment of RRMS: Canadian recommendations

September 4, 2013  
Previous
30
31
32
33
34
Next

Browse by Topic

  • MS (414)
  • CLINICAL CASES IN MS (16)
  • EPILEPSY (36)
  • AAN 2025 (5)
  • BIOMARKERS IN MS (54)
  • ACTRIMS 2025 (6)
  • Library (17)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • DMT prescribing in Canada – survey results posted on June 6, 2025
  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • CLINICAL CASES IN MS: A 42 Y.O. WOMAN WITH A SEVERE RELAPSE ON DMF posted on June 2, 2025
Copyright 2025 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions